V
Vicarious Surgical Inc
NYSE:RBOT
Vicarious Surgical Inc
NYSE:RBOT
Price:
0.96
USD
-7.69%
Market Closed
Market Cap:
$6.8m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
V
|
Vicarious Surgical Inc
NYSE:RBOT
|
US |
|
Aucma Co Ltd
SSE:600336
|
CN |
|
EPR Properties
NYSE:EPR
|
US |
|
Syrah Resources Ltd
ASX:SYR
|
AU |
|
K
|
Kerjaya Prospek Group Bhd
KLSE:KERJAYA
|
MY |
|
Amuse Group Holding Ltd
HKEX:8545
|
HK |
|
Pak Fah Yeow International Ltd
HKEX:239
|
HK |
|
R
|
Riken Technos Corp
TSE:4220
|
JP |
|
Washington Hotel Corp
TSE:4691
|
JP |
|
P
|
Prakash Pipes Ltd
BSE:542684
|
IN |
|
Lithium Argentina AG
NYSE:LAR
|
CH |
|
O
|
Organizacion Cultiba SAB de CV
BMV:CULTIBAB
|
MX |
|
Shinto Co Ltd
TSE:5380
|
JP |
Relative Value
The Relative Value of one RBOT stock under the Base Case scenario is hidden USD. Compared to the current market price of 0.96 USD, Vicarious Surgical Inc is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
RBOT Relative Value
HIDDEN
Multiples Across Competitors
RBOT Competitors Multiples
Vicarious Surgical Inc Competitors
Vicarious Surgical Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
V
|
Vicarious Surgical Inc
NYSE:RBOT
|
6.8m USD | 0.3 | -0.1 | 0.1 | 0.1 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
182.1B USD | 4.1 | 27.9 | 16 | 22 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
169.8B USD | 16.9 | 59.4 | 45.1 | 55.4 | |
| US |
|
Stryker Corp
NYSE:SYK
|
127.2B USD | 5.1 | 39.2 | 20 | 24.2 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
111.9B USD | 3.2 | 24.3 | 13.4 | 19.5 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
103.1B USD | 5.1 | 35.6 | 20.9 | 28.1 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
47.6B USD | 7.9 | 44.4 | 24.4 | 26.7 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
41.2B EUR | 1.8 | 19.7 | 11 | 15.6 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
46.1B USD | 10.7 | 43.5 | 30.9 | 34.1 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
44.5B USD | 2 | 25.3 | 10 | 16.9 | |
| US |
|
Resmed Inc
NYSE:RMD
|
33.2B USD | 6.2 | 22.3 | 15.7 | 17.4 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
